Quality: How serious are we?
Alok Ghosh, Ex-President - Global Technical Operations, Lupin, informs that with increasing competition and price control, it is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
483
The conundrum of USFDA inspections
Alok Ghosh, Ex-President - Global Technical Services, Lupin, shares insights on the challenges that India Pharma Inc faces with US…
Laurus Labs completes US FDA audit for Unit 4
The inspection was carried out from July 8 to 12 July 2019 Laurus Labs, a leading research and development-driven and…
Lupin clarifies on from 483s issued by US FDA for its Mandideep facility
The company believes that the observations are minor in nature and have been already addressed